India’s First Multi-Center Clinically Proven and Plant Based Medicine for Diabetes Gets Clearance from Ayush!

New Delhi (India), February 26: MB Lifesciences is proud to announce the launch of Diacea, a revolutionary medicine designed to combat type 2 diabetes effectively. With over a decade of expertise in health and wellness, MB Lifesciences has dedicated extensive research and clinical trials under the esteemed Ministry of Ayush to bring this innovative solution to fruition.

Diacea has received certification and recognition from the Ministry of Ayush, solidifying its status as a clinically proven and reliable treatment option. This groundbreaking medicine is not only effective in managing type 2 diabetes but also addresses various symptoms associated with the condition, offering comprehensive wellness support to individuals.

“Our team at MB Lifesciences is thrilled to introduce Diacea to the market,” said Dr. Ramakrishna, R&D head at MB Lifesciences. “We are committed to providing safe and efficacious solutions for individuals struggling with type 2 diabetes, and Diacea represents a significant milestone in our journey towards better health outcomes.”

Backed by scientific research and formulated with the highest quality ingredients, Diacea offers a holistic approach to diabetes management. Its effectiveness in addressing multiple symptoms of diabetes sets it apart as a leading option in the wellness landscape.

Experience the power of Diacea and take control of your diabetes journey with confidence. Visit mblifesciences.in to learn more about this groundbreaking product and its benefits.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.